BRPI0919973A2 - derivados de arilpiridona antivirais heterocíclicos - Google Patents

derivados de arilpiridona antivirais heterocíclicos

Info

Publication number
BRPI0919973A2
BRPI0919973A2 BRPI0919973A BRPI0919973A BRPI0919973A2 BR PI0919973 A2 BRPI0919973 A2 BR PI0919973A2 BR PI0919973 A BRPI0919973 A BR PI0919973A BR PI0919973 A BRPI0919973 A BR PI0919973A BR PI0919973 A2 BRPI0919973 A2 BR PI0919973A2
Authority
BR
Brazil
Prior art keywords
arylpyridone
derivatives
heterocyclic antiviral
antiviral
heterocyclic
Prior art date
Application number
BRPI0919973A
Other languages
English (en)
Inventor
Alfred Sui-Ting Lui
Francisco Xavier Talamas
Jim Li
Kristen Lynn Mccaleb
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BRPI0919973A2 publication Critical patent/BRPI0919973A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/44221,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/64One oxygen atom attached in position 2 or 6
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
BRPI0919973A 2008-10-30 2009-10-21 derivados de arilpiridona antivirais heterocíclicos BRPI0919973A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19794308P 2008-10-30 2008-10-30
PCT/EP2009/063811 WO2010049331A1 (en) 2008-10-30 2009-10-21 Heterocyclic antiviral arylpyridone derivatives

Publications (1)

Publication Number Publication Date
BRPI0919973A2 true BRPI0919973A2 (pt) 2015-12-08

Family

ID=41509812

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0919973A BRPI0919973A2 (pt) 2008-10-30 2009-10-21 derivados de arilpiridona antivirais heterocíclicos

Country Status (15)

Country Link
US (1) US8232271B2 (pt)
EP (1) EP2350007A1 (pt)
JP (1) JP2012506888A (pt)
KR (1) KR20110074941A (pt)
CN (1) CN102186823A (pt)
AR (1) AR074066A1 (pt)
AU (1) AU2009309813A1 (pt)
BR (1) BRPI0919973A2 (pt)
CA (1) CA2741325A1 (pt)
IL (1) IL211984A0 (pt)
MX (1) MX2011004133A (pt)
RU (1) RU2011121511A (pt)
TW (1) TW201020246A (pt)
WO (1) WO2010049331A1 (pt)
ZA (1) ZA201102607B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112012005616A2 (pt) * 2009-09-21 2016-06-21 Hoffmann La Roche compostos antivirais heterocíclicos
KR101322617B1 (ko) 2013-07-30 2013-10-29 이화전기공업 주식회사 배터리를 구비한 무정전전원장치의 에너지저장시스템 및 그 운전방법
US10364206B2 (en) 2015-04-13 2019-07-30 Sumitomo Seika Chemicals Co., Ltd. Method for producing 2-halogenated benzoic acids
AU2017219216B2 (en) * 2016-02-19 2019-12-19 Novartis Ag Tetracyclic pyridone compounds as antivirals

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6048823A (en) * 1996-02-02 2000-04-11 Kumiai Chemical Industry Co., Ltd. Pyridone derivatives and herbicides
JPH11140054A (ja) * 1997-07-31 1999-05-25 Kumiai Chem Ind Co Ltd 2−ピリドン誘導体及び除草剤
US6323180B1 (en) 1998-08-10 2001-11-27 Boehringer Ingelheim (Canada) Ltd Hepatitis C inhibitor tri-peptides
US20040034041A1 (en) 2000-05-10 2004-02-19 Dashyant Dhanak Novel anti-infectives
ATE437875T1 (de) * 2004-08-23 2009-08-15 Hoffmann La Roche Heterozyklische antivirale verbindungen
WO2008104473A2 (en) * 2007-02-28 2008-09-04 F. Hoffmann-La Roche Ag Pyrazolopyriidine derivatives and their use as kinase inhibitors
CN105693626A (zh) 2007-09-17 2016-06-22 艾伯维巴哈马有限公司 治疗丙型肝炎的尿嘧啶或胸腺嘧啶衍生物
TWI468407B (zh) 2008-02-06 2015-01-11 Du Pont 中離子農藥
WO2010010017A1 (en) * 2008-07-23 2010-01-28 F. Hoffmann-La Roche Ag Heterocyclic antiviral compounds
RU2552533C2 (ru) 2009-03-25 2015-06-10 Эббви Инк. Противовирусные соединения и их применения
CN105924386A (zh) 2009-03-25 2016-09-07 Abbvie 公司 抗病毒化合物和其用途

Also Published As

Publication number Publication date
CN102186823A (zh) 2011-09-14
ZA201102607B (en) 2011-12-28
KR20110074941A (ko) 2011-07-04
EP2350007A1 (en) 2011-08-03
WO2010049331A1 (en) 2010-05-06
JP2012506888A (ja) 2012-03-22
TW201020246A (en) 2010-06-01
CA2741325A1 (en) 2010-05-06
RU2011121511A (ru) 2012-12-10
AU2009309813A1 (en) 2010-05-06
IL211984A0 (en) 2011-06-30
US20100111900A1 (en) 2010-05-06
AR074066A1 (es) 2010-12-22
MX2011004133A (es) 2011-05-24
US8232271B2 (en) 2012-07-31

Similar Documents

Publication Publication Date Title
BRPI0916233A2 (pt) compostos heterocíclicos antivirais
BRPI0907435A2 (pt) Derivados de 5-flúor pirimidina
BR112012005616A2 (pt) compostos antivirais heterocíclicos
BRPI1010852A2 (pt) compostos antivirais heterocíclicos
BRPI0813707A2 (pt) Derivados de pirimidinil-piridazinona
BRPI0820112A2 (pt) Derivados de isoxazol-piridina
BRPI0809992A2 (pt) Derivados de pirrolopirimidina
BRPI0820113A2 (pt) Derivados de isoxazolo-piridazina
BRPI0812155A2 (pt) derivados de espiroindolinona
EP2266989A4 (en) HETEROCYCLIC DERIVATIVES
BRPI0915064A2 (pt) derivados de qunoxalinadiona
DK2308877T3 (da) Imidazopyridin-2-on-derivater
ATE539070T1 (de) Heterozyklische antivirale verbindungen
BRPI0817935A2 (pt) Derivados de biarila
BRPI0914544A2 (pt) derivados de pirimidona substituídos
ES2465673T9 (es) Derivados de pirimidina
BRPI0913832A2 (pt) derivados de pirrolopiridinilpirimidin-2-ilamina
BRPI0814236A2 (pt) Derivados de quinazolinamida
BRPI0821349A2 (pt) compostos antivirais heterocíclicos
BRPI0812518A2 (pt) Derivados de indazolamida
BRPI0924121A2 (pt) compostos antivirais heterocíclicos
BRPI0923497A2 (pt) derivados de piridazinona
BRPI0820649A2 (pt) Derivados de isoxazalo-pirazina
BR112012008108A2 (pt) derivados de xantina substituídos
BRPI0914301A2 (pt) derivados de pirimidin-4-ona substituída

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]